PCMT1 and neurodevelopmental disorder: Given the phenotype of the PIMT-KO mouse, extreme deficits in PIMT in humans would likely lead to neurodevelopmental disorders of the young, while moderate deficits might lead to an acceleration of age-related decline in CNS function.